Literature DB >> 24944069

An evaluation of the performance of the Opioid Manager clinical tool in primary care: a qualitative study.

Andrew Robertson1, Sander L Hitzig2, Andrea D Furlan3.   

Abstract

AIMS: The Opioid Manager (OM) is a point-of-care paper tool for physicians, which summarizes the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. To evaluate the efficacy of the OM, there is a need to better understand how physicians are using the OM, and how it is relevant to their practice.
METHODS: Semistructured interviews were conducted with six family physicians in Ontario with clinical pain management experience. The interviews were analyzed using content analysis. The technique of "code-recode" was conducted by two analysts to verify content validity.
RESULTS: The following main themes emerged: 1) OM as a communication tool; 2) OM as an educational tool; 3) OM as a clinical tool; 4) OM content/design; 5) OM benefits; 6) who the OM is used with; 7) OM potential; and 8) challenges of pain management. Physicians' commented the OM was a useful reference for helping their clinical decision making regarding opioids, and used it to educate and communicate with their patients/colleagues. Although many felt the content/design of the OM had a number of good features, there was a need for modifications (ie, merge with other tools and create electronic version). Given the challenges associated with pain management, a number of benefits were derived from using the OM (ie, protection and building therapeutic alliance), and respondents' felt the tool had the potential to meet a number of unmet needs related to opioid management.
CONCLUSIONS: Overall, the OM was viewed positively for improving pain management practices but further work is required to refine the tool's potential.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24944069     DOI: 10.5055/jom.2014.0207

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  3 in total

1.  Improving opioid safety practices in primary care: protocol for the development and evaluation of a multifaceted, theory-informed pilot intervention for healthcare providers.

Authors:  Pamela Leece; Daniel Z Buchman; Michael Hamilton; Caitlyn Timmings; Yalnee Shantharam; Julia Moore; Andrea D Furlan
Journal:  BMJ Open       Date:  2017-04-26       Impact factor: 2.692

2.  Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners.

Authors:  Tim Luckett; Toby Newton-John; Jane Phillips; Simon Holliday; Karleen Giannitrapani; Gawaine Powell-Davies; Melanie Lovell; Winston Liauw; Debra Rowett; Sallie-Anne Pearson; Bronwyn Raymond; Nicole Heneka; Karl Lorenz
Journal:  BMJ Open       Date:  2020-02-17       Impact factor: 2.692

3.  The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents.

Authors:  Winfried Häuser; Stephan Schug; Andrea D Furlan
Journal:  Pain Rep       Date:  2017-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.